Home  »  Companies   »  Here is a breakdown of major shareholders in Alaun...

Here is a breakdown of major shareholders in Alaunos Therapeutics Inc. (NASDAQ: TCRT)

Alaunos Therapeutics Inc. (NASDAQ: TCRT) is 72.48% higher on its value in year-to-date trading and has touched a low of $0.41 and a high of $4.01 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TCRT stock was last observed hovering at around $2.01 in the last trading session, with the day’s loss setting it -0.13% off its average median price target of $3.50 for the next 12 months. It is also 74.93% off the consensus price target high of $7.50 offered by 5 analysts, but current levels are 6.0% higher than the price target low of $2.00 for the same period.

Currently trading at $1.88, the stock is -32.82% and -7.10% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.04 million and changing -6.47% at the moment leaves the stock 66.22% off its SMA200. TCRT registered -0.53% loss for a year compared to 6-month gain of 174.45%.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.


The stock witnessed a 10.59% loss in the last 1 month and extending the period to 3 months gives it a 113.98%, and is -10.90% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 24.87% over the week and 26.77% over the month.

Alaunos Therapeutics Inc. (TCRT) has around 41 employees, a market worth around $342.99M and $0.40M in sales. Distance from 52-week low is 363.85% and -53.12% from its 52-week high. The company has generated returns on investments over the last 12 months (-94.20%).

Alaunos Therapeutics Inc. (TCRT) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Alaunos Therapeutics Inc. (TCRT) is a “Buy”. 5 analysts offering their recommendations for the stock have an average rating of 2.30, where 1 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Alaunos Therapeutics Inc. is expected to release its quarterly report on 11/07/2022.The EPS is expected to grow by 3.70% this year

Alaunos Therapeutics Inc. (TCRT) Top Institutional Holders

The shares outstanding are 215.00M, and float is at 193.29M with Short Float at 15.03%.

Alaunos Therapeutics Inc. (TCRT) Insider Activity

A total of 9 insider transactions have happened at Alaunos Therapeutics Inc. (TCRT) in the last six months, with sales accounting for 0 and purchases happening 9 times.

Alaunos Therapeutics Inc. (TCRT): Who are the competitors?

The company’s main competitors (and peers) include Statera Biopharma Inc. (STAB) that is -94.32% lower over the past 12 months. Bristol-Myers Squibb Company (BMY) is 18.52% up on the 1-year trading charts.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.